Proposals for special issues are welcome from:
Special issues may include reviews, original research, or case reports/case series. We accept proposals for special issues on both open and closed topics.
Open series: A potential Guest Editor contacts the Editorial Office about a possible special issue. If approved, the topic is listed on this page as an open invitation, i.e. unsolicited manuscripts are welcome. The Guest Editor may also send separate invites to potential authors to submit their manuscript.
Series with predefined participation: A sponsor or potential Guest Editor contacts the Editorial Office about a topic or conference theme and provides a list of authors and titles of manuscripts (potential or confirmed). Subject to the approval of topic/authors/titles, we will send submission instructions to the authors. Peer review and manuscript decisions are handled internally and independently from sponsors or Guest Editors.
Peer review: All articles for special issues/series undergo peer review. Peer review is performed independently from Guest Editors to ensure no conflicts of interest are encountered. Therefore, Guest Editors, where appropriate, can also participate as authors. Accepted papers after successful peer review are published as a Special Issue collection on this page and appear separately on the journal’s homepage.
Indexing: All articles are indexed on PubMed and free to view on PubMed Central.
Costs: Standard APC would apply for all Special Issue articles unless a fee waiver/special charge has been arranged.
Sponsorship: Sponsors may contact the Editorial Office directly to develop a Special Issue. All sponsorship would be declared on published papers, as is standard in the publication of any article. Please note that sponsored series are not obliged to involve a Guest Editor.
Heart failure is probably the area of cardiology that has grown the most in recent years with a likely turning point being, for example, the publication of results of the PARADIGM-HF study (Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure) in 2014, which is the largest study conducted to date in heart failure (8842 patients). For […]
Public and private hospitals around the world, and specifically in Latin America, have the necessity to diminish medicine costs, support their rational use and achieve patient safety. Nowadays, an important competent strategy to fulfil these goals is the implementation of different pharmaceutical services considering the characteristics and objectives of each hospital. All pharmaceutical services are […]
In recent years, advanced non-small-cell lung cancer has undergone tremendous progress in its management. On the one hand, the use of immune checkpoints inhibitors (anti-PD-(L)1 and anti-CTLA4) with or without chemotherapy has revolutionized the prognosis of a relevant number of patients; on the other hand, the discovery of several actionable genetic drivers in adenocarcinoma histology, […]
Breast cancer, one of the most common malignancies worldwide, is an example of complex disease. Clinical complexity is an increasingly recognized feature of internal medicine and oncology patients, who are often characterized by multifaceted needs determined by both biological (i.e. intrinsic to patient or disease biology) and non-biological (i.e. socioeconomic, cultural, environmental and behavioural) factors. […]